Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors.
about
Prognostic role of circulating tumor cells in patients with EGFR-mutated or ALK-rearranged non-small cell lung cancer.An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer.Minichromosome maintenance protein 2 correlates with the malignant status and regulates proliferation and cell cycle in lung squamous cell carcinoma
P2860
Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Targeted therapies in non-smal ...... S1 tyrosine kinase inhibitors.
@en
Targeted therapies in non-smal ...... S1 tyrosine kinase inhibitors.
@nl
type
label
Targeted therapies in non-smal ...... S1 tyrosine kinase inhibitors.
@en
Targeted therapies in non-smal ...... S1 tyrosine kinase inhibitors.
@nl
prefLabel
Targeted therapies in non-smal ...... S1 tyrosine kinase inhibitors.
@en
Targeted therapies in non-smal ...... S1 tyrosine kinase inhibitors.
@nl
P2093
P2860
P1476
Targeted therapies in non-smal ...... S1 tyrosine kinase inhibitors.
@en
P2093
Assunta Sgambato
Francesca Casaluce
Paolo Maione
P2860
P356
10.1080/14737140.2018.1412260
P577
2017-11-29T00:00:00Z